{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:23:12Z","timestamp":1779200592192,"version":"3.51.4"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Leiomyomas are prevalent benign smooth muscle tumors in the uterus, displaying variable degrees of FDG uptake on PET\/CT. The glucose metabolism intensity of those lesions relies on biologic features and markedly increased FDG accumulation is more typically related to malignant diseases, as in the case of leiomyosarcomas. Notwithstanding that uterine fibroids typically exhibit mild to moderate FDG uptake, in this article we report a case of unexpectedly intense hypermetabolism of a benign uterine leiomyoma on a PET\/CT scan performed for initial staging of a breast cancer patient.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002580","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T07:35:02Z","timestamp":1555313702000},"page":"e413-e414","source":"Crossref","is-referenced-by-count":15,"title":["Aberrant Hypermetabolism of Benign Uterine Leiomyoma on 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"44","author":[{"given":"Rafael F.","family":"Nunes","sequence":"first","affiliation":[{"name":"PET\/CT and Nuclear Medicine Department, Imaging Division;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo A.","family":"Queiroz","sequence":"additional","affiliation":[{"name":"PET\/CT and Nuclear Medicine Department, Imaging Division;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Alberto","family":"Buchpiguel","sequence":"additional","affiliation":[{"name":"PET\/CT and Nuclear Medicine Department, Imaging Division;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena Marino","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Department of Pathology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus Paula","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology\u2014Hospital S\u00edrio-Liban\u00eas, S\u00e3o Paulo, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/MNM.0000000000000558","article-title":"High metabolic characteristics of uterine fibroids in 18F-FDG PET\/CT imaging and the underlying mechanisms","volume":"37","year":"2016","journal-title":"Nucl Med Commun"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2967\/jnumed.112.113472","article-title":"18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis","volume":"54","year":"2013","journal-title":"J Nucl Med"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2214\/AJR.09.4074","article-title":"Spectrum of FDG PET\/CT findings of uterine tumors","volume":"195","year":"2010","journal-title":"Am J Roentgenol"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1097\/RLU.0000000000001330","article-title":"18F-FDG PET\/CT demonstrating malignant degeneration of a uterine fibroid","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ygyno.2006.09.024","article-title":"Positron emission tomography and leiomyomas: clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review","volume":"104","year":"2007","journal-title":"Gynecol Oncol"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s12149-008-0184-6","article-title":"Incidence and characteristics of uterine leiomyomas with FDG uptake","volume":"22","year":"2008","journal-title":"Ann Nucl Med"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1525-1438.2006.00778.x","article-title":"F-18 fluorodeoxyglucose uptake in leiomyomatous uterus","volume":"17","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1148\/rg.2017160059","article-title":"FDG PET\/CT pitfalls in gynecologic and genitourinary oncologic imaging","volume":"37","year":"2017","journal-title":"Radiographics"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2016.02.002","article-title":"Expression of the energy substrate transporters in uterine fibroids","volume":"123","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"bib10-20230925","first-page":"1","article-title":"Hemangioma of the rib showing a relatively high 18F-FDG uptake: a case report with a literature review","volume":"6","year":"2017","journal-title":"Acta Radiol Open"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201906000-00037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:12:22Z","timestamp":1695618742000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201906000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002580","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}